Gemzar and Micro-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gemzar (gemcitabine hydrochloride) and Micro-k (potassium chloride). Common drug interactions include arthralgia among females and bone pain among males.

The phase IV clinical study analyzes what interactions people have when they take Gemzar and Micro-k. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Gemzar?

Gemzar has active ingredients of gemcitabine hydrochloride. It is often used in pancreatic carcinoma. eHealthMe is studying from 20,315 Gemzar users. Check the latest studies of Gemzar.

What is Micro-k?

Micro-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,895 Micro-k users. Check the latest studies of Micro-k.



On Jul, 30, 2026

12 people who take Gemzar and Micro-k together, and have interactions are studied.

Gemzar and Micro-k drug interactions.

What are the common drug interactions of Gemzar and Micro-K, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Back pain
  4. Bone pain
  5. Decreased appetite
  6. Disability
  7. Dyspnoea (difficult or laboured respiration)
  8. Ear pain
  9. Fall
  10. General physical health deterioration (weak health status)

male:

  1. Bone pain
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Anxiety
  4. Aortic valve incompetence
  5. Arthralgia (joint pain)
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Ascites (accumulation of fluid in the abdominal cavity)
  8. Back pain
  9. Blood glucose decreased
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the common drug interactions of Gemzar and Micro-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal discomfort
  2. Anaemia (lack of blood)
  3. Anxiety
  4. Arthralgia (joint pain)
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Aspartate aminotransferase increased
  7. Back pain
  8. Blood alkaline phosphatase increased
  9. Blood calcium decreased
  10. Blood calcium increased

50-59:

  1. Abdominal pain
  2. Abscess (pus)
  3. Acanthosis (thickening of the skin)
  4. Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue)
  5. Alopecia (absence of hair from areas of the body)
  6. Anaemia (lack of blood)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Aortic valve incompetence
  10. Arthralgia (joint pain)

60+:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Abdominal pain
  3. Arthralgia (joint pain)
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Back pain
  7. Blood glucose decreased
  8. Bone pain
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Cardiomegaly (increased size of heart than normal)

What are the existing conditions these people have? *

  1. Pain: 5 people, 41.67%
  2. Breast Cancer Metastatic: 5 people, 41.67%
  3. Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 3 people, 25.00%
  4. Metastases To Bone (cancer spreads to bone): 3 people, 25.00%
  5. Breast Cancer: 3 people, 25.00%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
  7. Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
  8. Bone Loss: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Gemzar and Micro-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gemzar and Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gemzar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gemzar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micro-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gemcitabine hydrochloride and potassium chloride (the active ingredients of Gemzar and Micro-k, respectively), and Gemzar and Micro-k (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: